PDO MAX, Inc., a Liverpool, N.Y.-based woman-led medical device company, has launched its third product for 2023: the Glowpin serum infusion system. This device blends a multi-needle tool with a pump for applying skin serums. After the desired serum has been inserted into the device, pressing the pump infuses the serum for optimal absorption of skin boosters, hyaluronic acid, and other corrective serums into the skin.

The Glowpin syringe top, or multi-needle stimulator, is made of 19 equally spaced nano-hypodermic needles that infuse the serum onto the skin at 0.5mm, with minimal pain. This allows for the skin to absorb up to 30 times more of the skin booster when applied using the device. The single-use, multi-needle stimulator tip is versatile as it has a universal luer-locking system allowing it to attach to other syringes.

“When we introduced our proprietary PDO AfterGlo serum, our clients approached us about how to best maximize the delivery of our topical skin booster,” says PDO Max Founder Giovanna McCarthy.

“Our product team worked hard to find the best solution to the request, and we know that Glowpin will readily become the infusion system of choice for PDO AfterGlo serum and all other skin boosters in many medical aesthetic offices across the country,” she adds.